ACAD
$19.12-2.99%
ACADIA Pharmaceuticals Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.009%Russell 3000 0.005%US Stock Market 0.004%
ACAD financial statements
The full income statement, balance sheet, and cash-flow statement for ACADIA Pharmaceuticals Inc. (ACAD), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 165.9M2024-09 166.4M2024-12 166.8M2025-03 167.4M2025-06 168.7M2025-09 169.2M2025-12 170.5M2026-03 171.2M2026-06 172.3M+3.9% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 1.07B+11.9% | 958M+31.8% | 726M+40.4% | 517M+6.8% | 484M+9.6% | |
| — | — | 685M+35.1% | 507M+7.1% | 473M+9.7% | ||
| Cost of revenue | 89.0M+8.7% | 81.8M+96.6% | 41.6M+309.6% | 10.2M-46.9% | 19.1M+87.5% | |
| Research & development | 329M+8.4% | 303M-13.8% | 352M-2.8% | 362M+51.0% | 239M-25.0% | |
| Selling, general & administrative | 549M+12.4% | 488M+20.1% | 407M+10.2% | 369M-6.8% | 396M+1.9% | |
| Amortization of intangibles | 10.9M-27.2% | 15.0M+265.6% | 4.09M | 0.00-100.0% | 1.11M-25.0% | |
| Operating income | 105M-54.6% | 231M+414.5% | -73.4M+67.2% | -224M-31.2% | -170M+40.5% | |
| Other non-operating income | 2.37M+30.1% | 1.82M-64.3% | 5.11M+44.2% | 3.54M+52.1% | 2.33M+333.6% | |
| Equity-method income | 139M-46.2% | 258M+605.7% | -51.0M+76.1% | -213M-27.4% | -168M+40.4% | |
| Pre-tax income | 139M-46.2% | 258M+605.7% | -51.0M+76.1% | -213M-27.4% | -168M+40.4% | |
| Income tax | -252M-897.2% | 31.6M+208.5% | 10.3M+305.0% | 2.53M+621.1% | 351K-42.6% | |
| 391M+72.7% | 226M+469.5% | -61.3M+71.6% | -216M-28.7% | -168M+40.4% | ||
| Net income to common | 391M+72.7% | 226M+469.5% | -61.3M+71.6% | -216M | — | |
| $2.30+69.1% | $1.36+467.6% | -$0.37+72.4% | -$1.34-27.6% | -$1.05+41.3% | ||
| EPS (basic) | $2.32+69.3% | $1.37+470.3% | -$0.37+72.4% | -$1.34-27.6% | -$1.05+41.3% | |
| Weighted-avg shares (basic) | 168M+1.6% | 166M+1.2% | 164M+1.3% | 162M+0.7% | 160M+2.0% | |
| Weighted-avg shares (diluted) | 170M+2.1% | 166M+1.6% | 164M+1.3% | 162M+0.7% | 160M+2.0% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 1.06B+13.2% | 938M+52.3% | 616M+21.3% | 508M-17.8% | 618M-13.9% | ||
| Cash & equivalents | 178M-44.4% | 320M+69.4% | 189M+64.3% | 115M-22.1% | 147M-54.8% | |
| Accounts receivable | 121M+23.0% | 98.7M+0.5% | 98.3M+58.0% | 62.2M-3.4% | 64.4M+33.4% | |
| Inventory | 111M+21.5% | 91.7M+126.7% | 40.4M+249.9% | 11.6M-18.0% | 14.1M+45.6% | |
| Prepaid expenses | 59.5M+6.9% | 55.7M+42.4% | 39.1M+82.7% | 21.4M-10.4% | 23.9M-7.0% | |
| 1.56B+31.7% | 1.19B+58.6% | 749M+27.4% | 588M-16.0% | 700M-10.5% | ||
| Property, plant & equipment | 7.51M+78.2% | 4.21M-8.6% | 4.61M-23.4% | 6.02M-25.2% | 8.05M-12.2% | |
| Operating lease right-of-use | 47.4M+1.7% | 46.6M-10.2% | 51.9M-6.7% | 55.6M-4.6% | 58.3M+23.2% | |
| Intangible assets | 109M-9.1% | 120M+82.9% | 65.5M | 0.00 | 0.00-100.0% | |
| Deferred tax assets | 250M | 0.00 | — | — | — | |
| Other non-current assets | 3.90M+985.2% | 359K-24.6% | 476K-93.7% | 7.59M+89.8% | 4.00M+138.2% | |
| 277M-29.8% | 395M+55.3% | 254M+102.4% | 126M+30.8% | 96.1M-9.3% | ||
| Accounts payable | 10.9M-32.7% | 16.2M-7.7% | 17.5M+37.6% | 12.7M+85.4% | 6.88M-19.0% | |
| Accrued liabilities | 266M-29.7% | 379M+60.0% | 237M+109.7% | 113M+26.6% | 89.2M-8.5% | |
| Current lease liability | 11.6M+16.8% | 9.96M+5.9% | 9.40M+1.1% | 9.30M+12.1% | 8.30M+63.2% | |
| 337M-26.0% | 455M+43.4% | 317M+69.3% | 187M+17.7% | 159M+2.3% | ||
| Non-current lease liability | 40.6M-3.5% | 42.0M-12.1% | 47.8M-9.3% | 52.7M-6.1% | 56.1M+26.2% | |
| Operating lease liability (total) | 52.2M+0.4% | 52.0M-9.1% | 57.2M-7.7% | 62.0M-3.8% | 64.4M+30.0% | |
| Deferred tax liabilities | 11.2M-2.3% | 11.4M-7.8% | 12.4M-6.3% | 13.2M-5.9% | 14.1M+12.3% | |
| Other non-current liabilities | 19.1M+6.0% | 18.1M+19.2% | 15.1M+66.9% | 9.07M+29.0% | 7.03M+35.8% | |
| 1.23B+67.5% | 733M+69.7% | 432M+7.8% | 400M-26.0% | 541M-13.7% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 16.0K+0.0% | 16.0K+0.0% | 16.0K+0.0% | 16.0K+0.0% | 16.0K+0.0% | |
| Additional paid-in capital | 3.04B+3.5% | 2.94B+2.6% | 2.86B+3.3% | 2.77B+2.8% | 2.69B+3.1% | |
| Retained earnings | -1.81B+17.7% | -2.20B+9.3% | -2.43B-2.6% | -2.37B-10.0% | -2.15B-8.5% | |
| Accumulated other comprehensive income | 1.45M+394.9% | 292K+1116.7% | 24.0K+102.5% | -975K-407.8% | -192K-633.3% | |
| Total liabilities & equity | 1.56B+31.7% | 1.19B+58.6% | 749M+27.4% | 588M-16.0% | 700M-10.5% | |
| Common shares issued | 170M+2.2% | 167M+1.3% | 165M+1.6% | 162M+0.7% | 161M+0.9% | |
| Common shares outstanding | 170M+2.2% | 167M+1.3% | 165M+1.6% | 162M+0.7% | 161M+0.9% | |
| Shares outstanding (cover) | 170M+2.2% | 167M+1.2% | 165M+1.6% | 162M+0.6% | 161M+0.7% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 110M-30.4% | 158M+844.3% | 16.7M+114.6% | -114M+9.3% | -126M+7.7% | ||
| Depreciation & amortization | 11.8M-26.0% | 15.9M+186.1% | 5.55M+174.0% | 2.03M-39.4% | 3.34M+14.1% | |
| Intangible amortization | 10.9M-27.2% | 15.0M+265.6% | 4.09M | 0.00-100.0% | 1.11M-25.0% | |
| Share-based compensation | 52.1M-22.2% | 67.0M+0.9% | 66.4M-2.6% | 68.2M+7.2% | 63.6M-24.6% | |
| Deferred income taxes | -250M | 0.00 | 0.00-100.0% | 2.53M+621.1% | 351K | |
| Change in receivables | 22.7M+4713.1% | 472K-98.7% | 36.1M+1761.5% | -2.17M-113.5% | 16.1M+29.3% | |
| Change in inventory | 18.2M-63.3% | 49.5M+72.0% | 28.8M+1292.9% | -2.42M-157.4% | 4.21M+26.8% | |
| Change in payables | -5.29M-291.5% | -1.35M-128.2% | 4.80M-18.3% | 5.87M+463.0% | -1.62M-227.2% | |
| -303M-890.8% | -30.5M-195.4% | 32.0M-56.3% | 73.2M+203.0% | -71.1M-136.9% | ||
| Capital expenditure | 4.69M+796.7% | 523K+946.0% | 50.0K | 0.00-100.0% | 1.12M-85.2% | |
| Free cash flow | 105M-33.1% | 157M+844.0% | 16.7M+114.6% | -114M+10.1% | -127M+11.8% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 49.9M+628.8% | 6.84M-72.8% | 25.1M+206.5% | 8.20M-54.9% | 18.2M-77.6% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 49.9M+628.8% | 6.84M-72.8% | 25.1M+206.5% | 8.20M-54.9% | 18.2M-77.6% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | -143M-206.6% | 134M+81.5% | 73.8M+326.5% | -32.6M+81.8% | -179M-230.0% | |
| Income taxes paid | 25.2M+28.9% | 19.5M+233.7% | 5.85M+167.1% | 2.19M+111.0% | 1.04M-6.7% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 4.55B+48.8% | 3.06B-40.5% | 5.14B+99.4% | 2.58B-31.5% | 3.76B-56.0% | |
| P/E | 11.6×-13.8% | 13.5× | — | — | — | |
| P/S | 4.3×+33.0% | 3.2×-60.7% | 8.1×+61.4% | 5.0×-35.1% | 7.8×-59.9% | |
| P/B | 3.7×-11.2% | 4.2×-70.6% | 14.2×+134.4% | 6.1×-12.9% | 7.0×-49.0% | |
| P/FCF | 43.3×+122.4% | 19.5× | — | — | — | |
| Earnings yield | 8.6%+16.0% | 7.4% | — | — | — | |
| FCF yield | 2.3%-55.0% | 5.1% | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: ACAD’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ACAD filings on SEC EDGAR → Not investment advice.